Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyrogen vs. Liothyronine Withdrawal for Quality of Life in Thyroid Cancer
NCT00604318Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Feb 2008
- Primary completion
- Feb 2012
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of thyrotropin alfa in thyroid cancer, sponsored by Rigshospitalet. Primary endpoints: Visual Analog Scale at 3 weeks and Short Form 36 at 3 weeks. Started Feb 2008; status: completed.
02
Drugs
thyrotropin alfa
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT00604318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604318.